BioCentury
ARTICLE | Company News

Javelin management update

June 9, 2008 7:00 AM UTC

Javelin Pharmaceuticals Inc. (AMEX:JAV), Cambridge, Mass. Business: Neurology Transitioned: Daniel Carr to president while remaining vice chairman and CMO; he replaces Fred Mermelstein, who will becom...